S789 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn's Di...
S789 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn's Disease
About this item
Full title
Author / Creator
Publisher
Philadelphia, PA: Wolters Kluwer
Journal title
Language
English
Formats
Publication information
Publisher
Philadelphia, PA: Wolters Kluwer
Subjects
More information
Alternative Titles
Full title
S789 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn's Disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2583029574
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2583029574
Other Identifiers
ISSN
0002-9270
E-ISSN
1572-0241
DOI
10.14309/01.ajg.0000776688.39678.45